Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L, Perrone F, Garziera M, Farra R, Grassi M, Musiani F, Russo Spena C, Salis B, De Stefano L, Toffoli G, Rizzolio F, Tonon F, Abrami M, Chiarappa G, Pozzato G, Forte G, Grassi G, Dapas B. Scarabel L, et al. Among authors: rizzolio f. Expert Opin Drug Deliv. 2017 Jun;14(6):797-810. doi: 10.1080/17425247.2017.1292247. Epub 2017 Feb 17. Expert Opin Drug Deliv. 2017. PMID: 28266887 Review.
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness.
Farra R, Musiani F, Perrone F, Čemažar M, Kamenšek U, Tonon F, Abrami M, Ručigaj A, Grassi M, Pozzato G, Bonazza D, Zanconati F, Forte G, El Boustani M, Scarabel L, Garziera M, Russo Spena C, De Stefano L, Salis B, Toffoli G, Rizzolio F, Grassi G, Dapas B. Farra R, et al. Among authors: rizzolio f. Molecules. 2018 Mar 28;23(4):777. doi: 10.3390/molecules23040777. Molecules. 2018. PMID: 29597300 Free PMC article. Review.
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects.
Russo Spena C, De Stefano L, Poli G, Granchi C, El Boustani M, Ecca F, Grassi G, Grassi M, Canzonieri V, Giordano A, Tuccinardi T, Caligiuri I, Rizzolio F. Russo Spena C, et al. Among authors: rizzolio f. J Cell Physiol. 2019 Sep;234(9):15708-15716. doi: 10.1002/jcp.28224. Epub 2019 Jan 29. J Cell Physiol. 2019. PMID: 30697729
Strategies for Delivery of siRNAs to Ovarian Cancer Cells.
Farra R, Maruna M, Perrone F, Grassi M, Benedetti F, Maddaloni M, El Boustani M, Parisi S, Rizzolio F, Forte G, Zanconati F, Cemazar M, Kamensek U, Dapas B, Grassi G. Farra R, et al. Among authors: rizzolio f. Pharmaceutics. 2019 Oct 22;11(10):547. doi: 10.3390/pharmaceutics11100547. Pharmaceutics. 2019. PMID: 31652539 Free PMC article. Review.
STARD3: A Prospective Target for Cancer Therapy.
Asif K, Memeo L, Palazzolo S, Frión-Herrera Y, Parisi S, Caligiuri I, Canzonieri V, Granchi C, Tuccinardi T, Rizzolio F. Asif K, et al. Among authors: rizzolio f. Cancers (Basel). 2021 Sep 18;13(18):4693. doi: 10.3390/cancers13184693. Cancers (Basel). 2021. PMID: 34572920 Free PMC article. Review.
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor.
Adeel M, Saorin G, Boccalon G, Sfriso AA, Parisi S, Moro I, Palazzolo S, Caligiuri I, Granchi C, Corona G, Cemazar M, Canzonieri V, Tuccinardi T, Rizzolio F. Adeel M, et al. Among authors: rizzolio f. Int J Pharm. 2022 Feb 5;613:121374. doi: 10.1016/j.ijpharm.2021.121374. Epub 2021 Dec 11. Int J Pharm. 2022. PMID: 34906647
Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors.
Losurdo P, de Manzini N, Palmisano S, Grassi M, Parisi S, Rizzolio F, Tierno D, Biasin A, Grassi C, Truong NH, Grassi G. Losurdo P, et al. Among authors: rizzolio f. Pharmaceuticals (Basel). 2022 Oct 20;15(10):1295. doi: 10.3390/ph15101295. Pharmaceuticals (Basel). 2022. PMID: 36297407 Free PMC article. Review.
154 results